Exploring Current Evidence to Support the Expansion of GLP-1s into Renal Indications

Time: 1:30 pm
day: Conference Day One


  • Exploring the reasons behind the potential benefits of GLP-1s in this therapeutic domain, and assessing the necessity of creating novel treatments for renal diseases
  • Examining the supporting evidence for GLP-1s in renal indications to conclude their effectiveness in this patient population
  • Deliberating on challenges and future strategies to extend the application of GLP-1 therapies into this specific area